NHC vs. VRTX
Compare and contrast key facts about National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NHC or VRTX.
Correlation
The correlation between NHC and VRTX is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NHC vs. VRTX - Performance Comparison
Key characteristics
NHC:
-0.06
VRTX:
0.59
NHC:
0.12
VRTX:
0.90
NHC:
1.01
VRTX:
1.13
NHC:
-0.06
VRTX:
0.65
NHC:
-0.15
VRTX:
1.73
NHC:
12.36%
VRTX:
8.72%
NHC:
29.45%
VRTX:
25.50%
NHC:
-94.71%
VRTX:
-91.77%
NHC:
-30.95%
VRTX:
-6.29%
Fundamentals
NHC:
$1.90B
VRTX:
$124.35B
NHC:
$7.99
VRTX:
-$2.08
NHC:
0.00
VRTX:
1.34
NHC:
$928.59M
VRTX:
$11.01B
NHC:
$351.98M
VRTX:
$9.48B
NHC:
$162.68M
VRTX:
$486.30M
Returns By Period
In the year-to-date period, NHC achieves a -12.89% return, which is significantly lower than VRTX's 20.25% return. Over the past 10 years, NHC has underperformed VRTX with an annualized return of 7.01%, while VRTX has yielded a comparatively higher 15.32% annualized return.
NHC
-12.89%
-3.13%
-29.34%
-4.87%
5.49%
7.01%
VRTX
20.25%
13.14%
0.62%
13.46%
14.52%
15.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NHC vs. VRTX — Risk-Adjusted Performance Rank
NHC
VRTX
NHC vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NHC vs. VRTX - Dividend Comparison
NHC's dividend yield for the trailing twelve months is around 2.58%, while VRTX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NHC National HealthCare Corporation | 2.58% | 2.25% | 2.53% | 3.80% | 3.11% | 3.13% | 2.38% | 2.52% | 3.10% | 2.31% | 3.14% | 2.13% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NHC vs. VRTX - Drawdown Comparison
The maximum NHC drawdown since its inception was -94.71%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for NHC and VRTX. For additional features, visit the drawdowns tool.
Volatility
NHC vs. VRTX - Volatility Comparison
National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX) have volatilities of 8.63% and 8.72%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NHC vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between National HealthCare Corporation and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities